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Abstract 
Purpose:  To assess the “real time” self-management strategies employed by prostate cancer survivors to inform 
personalised supportive care interventions in the future.   
 
Method:  A purposive sampling framework was used to recruit men with different stages of cancer and treatment 
to an ecological momentary assessment (capturing experiences in real time) study.  Each participant was prompted 
by an audio alert to complete self-report questionnaires 3 times per day (93 data entries in total) for a total duration 
of 31 days.  A personal digital assistant (PDA) and pocket interview software was used. 
 
Results:  Prostate cancer survivors experienced a wide range of after-effects of therapy for which they used 
various self-management strategies.  Many of the men experienced sexual dysfunction but did not perform any 
self-management. 
 
Conclusion:  Our findings reinforce the importance of having access to tailored, timely and person-centred 
supported self-management care plans.  Real time monitoring data can provide helpful information to facilitate 
tailored recommendations for self-management.   
 
Implications for Cancer Survivors: 
Prostate cancer survivors can experience unmet supportive care needs which may increase men’s demands to 
perform self-management of their condition.  Future clinical intervention studies aimed at utilising the remote 
exchange of real time data serves to optimise tailored supported self-management.   
 
Key words:  Prostate cancer; self-management; mobile technology; real time; supportive care; ecological 
momentary assessment. 
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Introduction 
Prostate carcinoma is the most prevalent type of cancer in men [1].   Improved diagnostic techniques and 
treatments have dramatically improved survival rates [2].  However, men affected prostate cancer can experience 
profound decrements in quality of life, debilitating and challenging symptoms with psychosocial concerns.  
Distress can be related to sexual, urinary and bowel dysfunction, emotional difficulties and changes in perceptions 
of masculinity [3].  Prostate cancer is a long-term condition with numerous healthcare challenges. Prostate cancer 
survivors can experience unmet supportive care needs [4-14] in routine service delivery, which may exacerbate 
their own individual demands to perform self-management of their condition.  Men continue to report a lack of 
self-management advice in contemporary healthcare [4-14]. 
Self-management is a concept which specifically relates to an individual’s skill and capability to manage 
symptoms, physical and psychosocial after-effects of therapy, and adopting lifestyle modifications [15]. Clinical 
management of millions of prostate cancer survivors [16] in a stressed healthcare system imposes effective self-
management strategies on individuals [15, 17].  Generally, most men will have to adopt various self-manage 
strategies unsupervised from healthcare professionals in the community setting [4]. 
 
Two systematic reviews [18, 19] classified self-management in prostate cancer survivors.  On critical analysis 
both systematic reviews have limitations worthy of comment.  Firstly, the existing evidence base does not explore 
the influence of clinical and demographic factors which may influence self-management capabilities.  For 
example, employment status, cancer stage, treatments, marital status, level of education or multiple co-
morbidities.  Secondly, existing studies in this area do not assess how self-management behaviours performed by 
men change over time.  Thirdly, all existing studies in this area are subject to retrospective memory recall bias 
and cross-sectional designs.   
 
Ecological momentary assessment (EMA) encompasses real time self-report assessment methods in the 
individual’s naturalistic environment [20, 21].  Participants are audio prompted using mobile technology, such as 
a smart phone or personal digital assistant, at various times daily to self-report on their current state of mood, 
symptoms, or behaviours.  This novel approach to real time data collection reduces concerns over data fabrication 
and retrospective memory recall bias.  Therefore, studies which incorporate a novel design embedded in eHealth 
strategies [22, 23] and real time methodology [20]  are needed to identify gaps in self-management experiences 
to develop personalised supportive care interventions moving forward.  The assessment of real time self-
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management strategies may provide useful understandings about how healthcare professionals can enhance shared 
self-management care plans and identify potential barriers encountered while self-managing.   
 
Research questions 
I. What patient characteristics (clinical and demographic) influence agreement to participate in an EMA 
study? 
 
II. What self-management strategies are used, and do they change over time? 
 
Methods 
This study had National Health Service (NHS) ethical approval (10/S1402/7).  The setting was two large cancer 
hospitals in Scotland.  Inclusion criteria: capable to provide written informed consent, multidisciplinary team 
sanctioned diagnosis of prostate cancer irrespective of cancer stage or therapies, over 18 years of age, and self-
assessed proficiency in ability to read and write English.  Clinicians who considered patients to be psychologically 
or physically unfit were excluded from the study. Written informed consent was obtained for each participant.  
The current study formed part of a larger project [24, 25] and here we report the results of the EMA of the real 
time self-management behaviours.  
 
Ecological Momentary Assessment (EMA) 
 
We conducted an EMA study in prostate cancer survivors [26] according to the Checklist for Reporting EMA 
Studies (CREMAS) [27].  The study was informed by the theoretical model of social support [28, 29].    A total 
of n74 consented to participate in the prospective longitudinal survey (reported elsewhere), and of which, n62 of 
these participants also consented to take part in the EMA study.  Of the n62 who consented to the EMA study, 
n12 participants were purposively sampled. 
Sampling Framework 
A purposive sampling framework defined by: level of social support (as measured by the Berlin Social Support 
Scale [BSSS]) [30] at baseline recruitment as part of the prospective longitudinal survey [24], having a partner or 
not, and cancer stage.  The BSSS has good reliability >.80 and validity (31-35).  Previously reported data on the 
mean and standard deviation (SD) of social support scores (BSSS) for prostate cancer survivors was used to guide 
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the sampling framework [31-35].  The next step, was to calculate the means and SDs for the study participants in 
the prospective longitudinal survey [24]  at baseline.  The mean was identified as 3.2 (SD 0.6, [range 2.2 to 4.0]).  
Twelve participants were purposively sampled by applying 1 SD (2.6) below the mean and 1 SD (3.8) above the 
mean to designate high and low social support, see Table 1.    
The sampling framework was important for several clinical reasons.  Firstly, it facilitated an exploration of the 
influence of support on self-management strategies and evaluated self-management across different stages of 
prostate cancer. 
 
Electronic Behavioural Diary  
A small digital personal assistant (Dell Axim X51) with Pocket Interview software was used.  Twelve participants 
is a recommended sample size for this type of study design  [36]. The digital personal assistant hosted Pocket 
Interview software [37] and used a RC4 cipter.  Prior to the EMA study pilot work was carried out and a steering 
group convened.  The steering group panel consisted of researchers, prostate cancer survivors and clinicians.  The 
pilot work ensured patient involvement in the co-design [38] and provided an essential opportunity to address any 
technical issues and explored considerations of acceptability and face validity.  The pilot study specifically was 
conducted in two distinct phases.  The first part involved 11 pilots with colleagues and acquaintances, and the 
second part, comprised of three pilots with prostate cancer survivors. This work resolved technical problems and 
collated essential information on the scheduling and contents of the EMA study. 
 
Data Collection 
The schedule of the EMA data collection were informed by prostate cancer survivors and clinicians (see Table 
2).  Data collection was signal contingent (alerted by an audio signal) at fixed time points throughout each day 
(although the timings differed from participant to participant) using the electronic behavioural diary.  We also 
included an event contingent data collection which enabled the capture of experiences as they randomly occurred 
in the real world [20].  Signal contingent data collection was completed at 3 pre-determined intervals per day for 
a total of 1 month (totalling 93 data points). The individual timings were tailored by factors such as employment 
commitments, lifestyle, sleeping and waking times, etc.  Signal contingent data collection were at intervals equally 
spaced (i.e. 8am, 2pm, and 8pm). The “snooze function” enabled a delay in the participant completing the 
electronic questionnaire from 5 to 60 minutes if the timing was inconvenient. The participants were provided with 
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written and verbal instruction on how to complete the data collection.  The twelve participants were provided with 
a curtesy telephone conversation on the second day of their data collection answer any questions and resolve any 
technical problems. After the one month of data collection the electronic device was retrieved from the participant 
and the data safely downloaded to a secure database. 
 
Outcome Variables 
SELF-MANAGEMENT STRATEGIES:  Questionnaire items were informed by self-management diary research 
within cancer care [19, 39-41] and involvement from prostate cancer survivors and clinicians.  The questions were 
structured to address: 1) symptom, 2) strategies/behaviours performed, and 3) the outcome of the action.  Self-
management item questions were asked in relation to bowel, urinary, and sexual function (see Figure 1 for 
example of the electronic diary and the sexual function self-management options).  To assess other symptoms or 
problems for which self-management was performed we asked, “Did you use any other self-care activities (not 
already mentioned) to help alleviate your symptoms/problems today?” and participants responded by “tapping” a 
box on the PDA screen to indicate “yes or no”.   If “yes” was selected, “Please describe the problem/symptom 
for which you carried out your self-care”, “Please describe the self-care tasks” was automatically prompted.  
The questions were answered by digitally typing letters with a stylus to form words on the PDA screen.  To 
evaluate the perceived effectiveness of the various self-management strategies, “Generally, did your self-care 
actions relieve this problem?” was anchored by “not at all/completely” (scale anchor 0-100). 
SELF-MANAGEMENT DEMAND AND CONTROL:  Questions included: “How demanding has self-care been 
for you?”, “how much control have you had over your self-care?” answered by “not at all/completely” (scale 
anchor 0-100).  Finally, participants were asked “What was your most demanding self-care task that you had to 
do today”? 
HEALTH-RELATED QUALITY OF LIFE:  Question items were constructed by the EORTC C30 and PR25 
questionnaires [42, 43].  “How would you rate your quality of life today?” answered by “very poor/excellent” 
(scale anchor 0-100), and “To what extent have you experienced the following symptoms today? (blood in the 
urine, constipation, diarrhoea, nausea, pain, tiredness, unable to sleep, urgency to pass urine, urinate frequently 
day, urinate frequently night, vomiting, erectile dysfunction)” answered “not at all/always” (scale anchor 0-100).   
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Results 
No statistically significant differences were observed employment, marital status, co-morbidity and gleason score 
variables between those who consented to the EMA study and those who did not (see Table 3, Fisher’s exact test 
P>0.05, 2-tailed).  It was not possible to explore the relationship with education, socio-economic, and treatment 
using Chi²-test as the assumptions were not met.  We observed a statistically significant association between 
participation in the EMA study and cancer stage: χ2 (2)=12.765, p=0.002.  Men with metastatic prostate cancer 
were less likely to consent to the EMA study, but due to the small numbers caution should be taken in the 
interpretation. 
Four participants had localised prostate cancer, five participants had locally advanced prostate cancer, and three 
men had metastatic cancer.  Regrettably, Mr L’s data was unable to be retrieved from the PDA. Mr L articulated 
excellent compliance with the EMA study, but forgot to tap the finish key at each entry.  Overall, response rates 
were very high to the EMA study, >90%. 
  
Prostate cancer survivors’ self-management  
Men experienced a wide range of after-effects after treatment.  Generally, self-management strategies were used 
to relieve urinary, bowel and sexual dysfunction.  However, men also reported other symptoms which included: 
infected wound, severe rectal pain, poor sleeping, morning sickness, radiation burns to penis and problems with 
relaxation for which participants implemented self-management strategies, see Table 4. The frequency of self-
management activity varied over time, see Table 5.  The two men who were receiving androgen deprivation 
therapy for their metastatic prostate cancer did not report any self-management strategies at all, despite 
experiencing a range of problematic symptoms.   
Self-management strategies demonstrated variation across the participants so did the self-management relief over 
time.   The real time series data across all the participants demonstrated the unique variation in symptom 
experience and self-management experience that traditional research methodologies are unable to measure (see 
Figure 2, for exemplar).  Sexual well-being self-management was infrequently performed across the 11 prostate 
cancer survivors and the reasons for this are unclear.  A commonality for Mr B, Mr G, Mr I, was identified in that 
they reported to have low social support and collectively, they all stated that they experienced inadequate symptom 
relief from their self-management strategies.   
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Discussion 
This innovative EMA study sought to identify the real time self-management behaviours of prostate cancer 
survivors over time.   We also investigated potential sources of bias in relation to participation in this ecological 
momentary assessment study.  Overall, acceptability to participate in this unique study was high (83.8%) with 
high data collection responses rates (<90%).  This study has demonstrated that future digitalised real time 
assessments in this older patient group are acceptable, and refutes the widely accepted perceptions of the barriers 
to engaging an aging population in future eHealth studies [44].  The acceptability of this innovative study for 
participants was enhanced by the co-design with service users and prostate cancer clinicians.       
We did not identify any statistically significant differences between those who agreed to participate in the EMA 
study across a range of clinical and demographic variables.  However, men with metastatic prostate cancer were 
less likely to agree to take part in an EMA study, but due to the small participant numbers caution should be taken.  
One explanation, which might be offered is in relation to the burden of metastatic prostate cancer on quality of 
life [6, 45], which might have influenced their decision to participate.  Ultimately, this will remain unknown.   
Self-management strategies varied in relation to prostate cancer specific domains of health-related-quality-of-life, 
specifically, urinary, bowel and sexual dysfunction over time.  Men who received radical therapy (radiotherapy 
and surgery) performed self-management more often compared to men on active surveillance.  However, men 
affected by incurable metastatic prostate cancer receiving androgen deprivation therapy did not report any self-
management despite the frequency of their reported symptoms.  The reasons why they did not perform any self-
management is unknown, but several explanations are offered.  Clinically, metastatic prostate cancer can result in 
physical and psychological sequalae which can include: body feminization (gynecomastia, hot flushes, genital 
shrinkage, loss of muscle mass),  sexual dysfunction and lack of libido, relationship changes, cognitive and 
affective symptoms, and sleep disturbance, depression and fatigue [46-52] which could afford various self-
management strategies.  However,  a considerable body of evidence now exists that prostate cancer survivors can 
experience distressing unmet supportive care needs and a lack of self-management advice [5, 7, 9, 12, 14, 53-56], 
in particular men diagnosed with metastatic prostate cancer [5, 47, 57-59] .  Therefore, future research should be 
prioritised to investigate the potential association between self-management strategies and the experience of 
unmet supportive care needs specifically for men affected by metastatic prostate cancer [6, 45]. 
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Implications for practice 
This EMA study provides the first real time assessment of the strategies that prostate cancer survivors used to 
cope and reduce their symptoms. This methodology can provide a clinical tool for healthcare providers to assess 
the diverse strategies patients use and to support and tailor the most effective self-management techniques to 
alleviate their symptoms. We observed that all participants experienced a range of symptoms.  Noteworthy, few 
men reported self-management strategies to alleviate erectile dysfunction (ED) across the case series.  The reasons 
for this are unknown.  Healthcare professionals should offer a proactive approach to evidence-based interventions 
for ED in routine clinical consultation [60] including prehabiliation self-management support [61].  Healthcare 
professionals must elicit an understand about the connection between symptom experience (bother, frequency and 
severity) and its relationship with self-management strategies to further advance new knowledge and 
understanding over the cancer care continuum [62].  Prostate cancer survivors performed diverse self-management 
strategies to improve their overall quality of life.  Three men described ineffective outcomes from their self-
management strategies on their symptoms and had low social support.  In keeping with social support theory, 
these men may not have had access to informational, practical and emotional support to help them alleviate and 
cope with their symptoms [4].   
 
The symptom experience is complex and multidimensional.  Healthcare professionals need to elicit prostate cancer 
survivors interpretations of various symptoms [41].  This study has demonstrated that prostate cancer survivors 
evaluate their symptoms daily.  Men will make decisions about the cause, severity, treatability, and impact of the 
symptoms on their quality of life.  Healthcare professionals need to elicit this information accurately to tailor 
supported-self-management care plans which are customised to each patient’s needs [41, 62].  An understanding 
of fundamental factors such as: timing (frequency of occurrence), symptom intensity (severity), level of perceived 
distress (bother), and perceived self-efficacy [63] are needed to support men in their recovery and tailored self-
management care plans.   
 
Limitations 
We evaluated self-management strategies used by men with different levels of social support and clinical 
characteristics, enabling some replication.    However, this study was at risk of habituation and reactivity due to 
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repeated exposure to the electronic diary questions over time.  Several symptoms were not explicitly assessed as 
a potential limitation; however, participants could report on any symptoms using “free text”.  Moreover, as real 
time methodologies in cancer care is an emerging science there are no existing standardised questionnaires 
available with demonstrated reliability or validity.   Future studies should focus efforts on developing robust 
standardised tools for eventual use by researchers and clinical teams.   
Conclusion  
This study was designed move beyond traditional studies which are plagued with retrospective memory recall 
bias.  We aimed to advance science in the understanding of real time symptom experience and the self-
management strategies used across different stages of cancer, treatment modalities and level of support.  This real 
time approach to capturing prostate cancer survivors experience serves as the basis for future intervention studies 
aimed at utilising the remote exchange of data and communication between patients and health care professionals.  
Our findings reinforce the clinical need that healthcare professionals must recognise the support needs and 
symptom-related-distress to provide timely and person-centred supported self-management plans. 
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Table 1.   Sampling framework  
 
 Localised prostate cancer Locally advanced prostate cancer Metastatic prostate cancer 
Partner high social support 3.8 ≥ 
low social support 2.6 ≤ 
high social support 3.8 ≥ 
low social support 2.6 ≤ 
high social support 3.8 ≥ 
low social support 2.6 ≤ 
No partner high social support 3.8 ≥ 
low social support 2.6 ≤ 
high social support 3.8 ≥ 
low social support 2.6 ≤ 
high social support 3.8 ≥ 
low social support 2.6 ≤ 
 Total = 12 ecological momentary assessment studies.  
 
 
 
Table 2.   Data collection timings  
Treatment Timing of data collection 
Radical Prostatectomy (RP)  
 
1 month after RP  
 
External Beam Radiotherapy (EBRT)  
 
1 month after EBRT  
 
Androgen deprivation therapy 
 
No timing restrictions  
Active surveillance (AS)  
 
No timing restrictions  
Brachytherapy (BT)  
 
1 month after BT  
 
 
 
 
 
 
 
Table 3 Comparisons between those who consented to EMA and those who did not  
Variables Consented to complete the electronic diary 
(n=62, 83.8%) 
Did not consent to completing the electronic diary (n=12, 16.2%) Comparisons 
Age (years) at study consent 69.7 (SD 7.8) 72.0 (SD 9.4) t(72)=0.914, p=0.361 
Education 
High school 
Further education  
Higher education 
Trade qualification 
No qualifications  
 
9.7% (n=6) 
22.6% (n=14) 
22.6% (n=14) 
40.3%(n=25) 
4.8% (n=3) 
 
8.3% (n=1) 
8.3% (n=1) 
33.3% (n=4) 
16.8% (n=2) 
33.3% (n=4) 
 
The assumption for ‘minimum expected cell 
frequency’ was not met for the Chi² -test. 
School leaving age (years) 16.2 (SD 1.4) 15.9 (SD 1.5) t(72)=-1.232, p=0.221 
Employment 
Unemployed 
Employed 
Retired 
 
3.2% (n2) 
29.0% (n18) 
67.7% (n42) 
 
0% (n0) 
41.7% (n5)  
58.3% (n7) 
The Chi²-test was performed with employed 
and retired categories only, because the 
participants in the unemployed categories 
(n=2) were very small for the entire study 
sample. χ2  (1)=0.626, p=0.431 Fisher’s Exact 
Test p=0.502, (2-tailed). 
Socio-economic (SIMD) 
1 most deprived 
2 
3 
4 
5 Least deprived 
 
3.2% (n2) 
6.5% (n4) 
16.1% (n10) 
48.4% (n30) 
25.8% (n16) 
 
16.7% (n2) 
16.7% (n2) 
25.0% (n3) 
25.0% (n3) 
16.7% (n2) 
 
The assumption for ‘minimum expected cell 
frequency’ was not met for the Chi²-test. 
Martial 
Partner 
No partner 
 
80.6% (n50) 
19.4% (n12) 
 
83.3% (n10) 
16.7% (n2) 
 
χ2  (1)=0.047, p=0.833. Fisher’s Exact Test 
p=1.0 (2-tailed) 
Cancer stage 
Localised 
Locally advanced 
Metastatic 
 
43.5% (n27) 
50.0% (n31) 
6.5% (n4) 
 
41.7% (n5) 
16.7% (n2) 
41.7% (n5) 
 
χ2 (2)=12.765, p=0.002, Cramer’s V statistic 
=0.415, p=0.002.** 
Cancer treatment 
Watchful waiting 
RRP 
LRP 
EBRT 
Hormone therapy 
Active surveillance 
Hormone therapy and EBRT 
 
4.8% (n3) 
1.6% (n1) 
11.3% (n7) 
9.7%  (n6) 
14.5%  (n9) 
11.3%  (n7) 
46.8% (n29) 
 
0% (n0) 
0% (n0) 
8.3% (n1) 
0% (n0) 
41.7% (n5) 
16.7% (n2) 
33.3% (n4) 
 
The assumption for ‘minimum expected cell 
frequency’ was not met for the Chi²-test. 
PSA 26.1 (SD 31.8) 56.6 (SD 86.6) t(11.6)=1.205, p= 0.253  
 
Gleason 
Low grade (2-4) 
Intermediate grade (5-7) 
High grade (8-10) 
 
0 % (n0) 
74.2% (n46) 
25.8% (n16) 
 
0% (n0) 
58.3% (n7) 
41.7% (n5) 
 
χ2  (1)=1.244, p=0.262. Fisher’s Exact Test 
p=0.303, 2-tailed) 
Existing co-morbidity (yes) 
 
71.0% (n44) 58.3% (n7) χ2  (1)=0.749, p=0.384 Fisher’s Exact Test 
p=0.498, (2-tailed) 
*p<0.05, **p<0.01 
Table 4.  Self-management  
 Symptoms Self-management  
Urinary 
dysfunction 
Urinary incontinence 
Urinary frequency (during day) 
Urinary frequency (during the 
night) 
Urinary urgency 
Blood in the urine 
Found out more information 
Used continence pads 
Took medication (anticholinergics, ie. Tolterodine) 
Increased oral fluid intake 
Used catheter sheaths 
Avoided heavy lifting of objects 
Reduced caffeine intake (switched to decaffeinated 
alternatives) 
Shared thoughts and feelings with friends and family 
Drank cranberry juice 
Kept a toileting diary (urinary and bowel patterns) 
Reduced alcohol intake 
Washed incontinence pads (re-usable ones) 
Mind over matter strategies  
Bowel 
dysfunction 
Diarrhoea 
Constipation 
Bleeding from anus 
Rectal pain 
 
Took medication 
Took a high fibre diet 
Took califig/fybogel 
Changed fluid intake 
Applied anusol  
Used continence pads 
Shared my thoughts and feelings with friends and loved 
ones 
Changed and modified diet 
Kept a toileting diary 
Took physical exercise 
Sexual 
dysfunction 
Impotence Used a penis pump 
Found out information 
Shared thoughts and feelings with friends and family 
Took medication (Viagra) 
Limited alcohol intake 
Found ways to reduced stress 
 
Other Ankle oedema Took furosamide pill 
Went for a walk regularly  
Elevated feet when sitting down 
Other Infected surgical wound Sought help from nurse and doctor 
Dressed wound  
Changed and emptied wound drainage bag 
Took antibiotic tablets 
Other Poor sleeping patterns/problems 
with relaxation 
Took a large whisky before bed 
Increased amitriptyline dosage 
Other Morning sickness Took anti-sickness tablets 
Other Radiation burns to abdomen and 
penis 
Applied savlon and aqueous cream 
Applied gel medication 
Wiped tip of penis after urinating 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Table 5  The number of days that self-management was performed  
 Social support Clinical details Self-management of 
urinary symptoms 
Self-management of bowel 
symptoms 
Self-management of 
sexual function 
symptoms 
Mr A,  
73 years old, retired  
Partner high 
support 
Localised cancer AS 
 
Comorbidity:  None 
5 days None None 
Mr B,  
61 years old, 
employed 
Partner low 
support 
Localised cancer AS 
 
Comorbidity:  None 
29 days None  None 
Mr C,  
51 years old, 
employed 
Partner high 
support 
Localised cancer LRP 
 
Comorbidity:  None 
31 days 8 days 1 day 
Mr D,  
59 years old, retired 
Partner high 
support 
Localised cancer LRP 
 
Comorbidity:  None 
30 days None  None 
Mr E,  
65 years old, retired 
Partner high 
support 
Locally advanced cancer ADT and EBRT 
 
Comorbidity:  None 
None 3 days None  
Mr F,  
57 years old, 
employed 
Partner high 
support 
Locally advanced cancer ADT and EBRT 
 
Comorbidity:  None 
25 days 3 days None 
Mr G,  
64 years, retired 
Partner low 
support 
Locally advanced cancer ADT and EBRT. 
 
Comorbidity:  Asthma, Hypertension, 
Depression 
31 days 31 days None 
Mr H,  
73 years old, 
employed 
No partner high 
support 
Locally advanced cancer ADT and EBRT 
 
Comorbidity:  None 
12 days 13 days 11 days 
Mr I,  
73 years old, retired 
No partner low 
support 
Locally advanced cancer ADT and EBRT 
 
Comorbidity: Asthma, Hypertension 
30 days 30 days 1 day 
Mr J,  
73 years old, retired 
Partner low 
support 
Metastatic cancer ADT 
 
Comorbidity:  None 
None None None 
Mr K,  
72 years old, retired 
Partner high 
support 
Metastatic cancer ADT 
 
Comorbidity:  None 
None None None 
 
 
